---
category: trading
circular_id: 83deb4ef089c91da
date: '2026-01-13'
description: Rekvina Laboratories Ltd. equity shares will be moved to 'X' group effective
  January 20, 2026.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={B76CAF34-D820-416B-8825-7C4DEBD75FF5}&noticeno=20260113-11&dt=01/13/2026&icount=11&totcount=50&flag=0
impact: high
impact_ranking: high
importance_ranking: high
justification: Movement to X group typically indicates serious compliance issues or
  regulatory concerns, significantly affecting trading and investor sentiment for
  the stock.
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20260113-11&attachedId=
processing:
  attempts: 1
  content_hash: 58302179eb890603
  processed_at: '2026-01-13T18:55:04.576856'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2026-01-13T09:44:19+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={B76CAF34-D820-416B-8825-7C4DEBD75FF5}&noticeno=20260113-11&dt=01/13/2026&icount=11&totcount=50&flag=0
severity: high
source: bse
stocks:
- REKVINA
tags:
- group-change
- x-group
- rekvina-laboratories
- '526075'
- trading-suspension-risk
title: 'Change in Group of Equity Shares of Rekvina Laboratories Ltd. (Scrip Code:
  526075)'
---

## Summary

BSE has announced that the equity shares of Rekvina Laboratories Ltd. (Scrip Code: 526075) will be moved to the 'X' group effective January 20, 2026. The 'X' group classification typically indicates securities with compliance or regulatory concerns.

## Key Points

- Rekvina Laboratories Ltd. (Scrip Code: 526075) to be included in 'X' group
- Effective date: January 20, 2026
- Notice issued by BSE on January 13, 2026
- Contact person: Mrs. Kinjal More, Cell: +91-7304278788

## Regulatory Changes

The equity shares of Rekvina Laboratories Ltd. will be transferred from their current trading group to the 'X' group. The 'X' group is a special category where securities are placed when there are concerns about the company's compliance, corporate governance, or other regulatory issues. Trading in 'X' group securities may have restrictions or additional scrutiny.

## Compliance Requirements

- Trading members must note the group change for Rekvina Laboratories Ltd.
- All trades in this scrip must comply with 'X' group trading rules and restrictions from January 20, 2026
- Members requiring clarification should contact the designated BSE officials

## Important Dates

- **Notice Date:** January 13, 2026
- **Effective Date:** January 20, 2026

## Impact Assessment

**Market Impact:** High - Movement to 'X' group typically results in reduced liquidity, increased price volatility, and negative investor sentiment. The stock may face selling pressure as institutional investors often avoid 'X' group securities.

**Trading Impact:** Trading restrictions and additional surveillance measures will apply. The stock may experience wider bid-ask spreads and difficulty in execution of large orders.

**Investor Impact:** Existing shareholders should be aware that this change signals regulatory concerns. Investors should exercise heightened caution and conduct thorough due diligence before taking any position in this security.